Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome

Stem Cells

Volumn 32, Issue 11, 2014, Pages 3031-3036

  El Helou, Rita ^a,b,c,d   Wicinski, Julien ^a,b,c,d   Guille, Arnaud ^a,b,c,d   Adélaïde, Jose ^a,b,c,d   Finetti, Pascal ^a,b,c,d   Bertucci, François ^a,b,c,d   Chaffanet, Max ^a,b,c,d   Birnbaum, Daniel ^a,b,c,d   Charafe Jauffret, Emmanuelle ^a,b,c,d   Ginestier, Christophe ^a,b,c,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d CNRS   (France)

Author keywords

Breast cancer; Cancer stem cells; Differentiation; Methylation

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FEMALE; GENETICS; HUMANS; METABOLISM; NEOPLASTIC STEM CELLS; PHYSIOLOGY;

BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FEMALE; HUMANS; NEOPLASTIC STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907905879     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1792     Document Type: Article

References (30)

1. Valent P, Bonnet D, De MR, et al. Cancer stem cell definitions and terminology: The devil is in the details. Nat Rev Cancer 2012; 12: 767-775.
2. Visvader JE, Lindeman GJ,. Cancer stem cells: Current status and evolving complexities. Cell Stem Cell 2012; 10: 717-728.
3. Meacham CE, Morrison SJ,. Tumour heterogeneity and cancer cell plasticity. Nature 2013; 501: 328-337.
4. Liu S, Wicha MS,. Targeting breast cancer stem cells. J Clin Oncol 2010; 28: 4006-4012.
5. Bird A,. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6-21.
6. Bock C, Beerman I, Lien WH, et al. DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell 2012; 47: 633-647.
7. Bloushtain-Qimron N, Yao J, Snyder EL, et al. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci USA 2008; 105: 14076-14081.
8. Maruyama R, Choudhury S, Kowalczyk A, et al. Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet 2011; 7: e1001369.
9. Pal B, Bouras T, Shi W, et al. Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2. Cell Rep 2013; 3: 411-426.
10. Salvador MA, Wicinski J, Cabaud O, et al. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin Cancer Res 2013; 19: 6520-6531.
11. Tsai HC, Li H, Van NL, et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 2012; 21: 430-446.
12. Hernandez-Vargas H, Ouzounova M, Le Calvez-Kelm F, et al. Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics 2011; 6: 428-439.
13. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009; 69: 1302-1313.
14. Ohm JE, McGarvey KM, Yu X, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39: 237-242.
15. Widschwendter M, Fiegl H, Egle D, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39: 157-158.
16. Feinberg AP, Ohlsson R, Henikoff S,. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7: 21-33.
17. Hodges E, Molaro A, Dos Santos CO, et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 2011; 44: 17-28.
18. Ji H, Ehrlich LI, Seita J, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010; 467: 338-342.
19. Cornen S, Guille A, Adelaide J, et al. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling. PLoS One 2014; 9: e81843.
20. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
21. Bhola NE, Balko JM, Dugger TC, et al. TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer. J Clin Invest 2013; 123: 1348-1358.
22. Bruna A, Greenwood W, Le QJ, et al. TGFbeta induces the formation of tumour-initiating cells in claudinlow breast cancer. Nat Commun 2012; 3: 1055.
23. Chaffer CL, Marjanovic ND, Lee T, et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013; 154: 61-74.
24. Thillainadesan G, Chitilian JM, Isovic M, et al. TGF-beta-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell 2012; 46: 636-649.
25. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
26. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010; 16: 45-55.
27. Pece S, Tosoni D, Confalonieri S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010; 140: 62-73.
28. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009; 69: 4116-4124.
29. Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007; 356: 217-226.
30. Charafe-Jauffret E, Ginestier C, Bertucci F, et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res 2013; 73: 7290-7300.